INT-001(inTumo Therapeutics)

N/A

Report date: 2025/02/18 13:57:09
NME

Base Information

Drug NameINT-001(inTumo Therapeutics)
Drug Alias NameINT001INT-001INT-001( inTumo Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTurkey
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesinTumo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesinTumo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A